DrugPatentWatch Database Preview
Human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant - Biologic Drug Details
Summary for human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant
| Tradenames: | 1 |
| Patents: | 5 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 2 |
US Patents for human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck Sharp & Dohme Corp. | GARDASIL | human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant | INJECTION, SUSPENSION | 125126 | 001 | 2006-06-08 | ➤ Sign Up | Chevron Phillips Chemical Company LP (The Woodlands, TX) | ➤ Sign Up | search | ||
| Merck Sharp & Dohme Corp. | GARDASIL | human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant | INJECTION, SUSPENSION | 125126 | 001 | 2006-06-08 | ➤ Sign Up | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | ➤ Sign Up | search | ||
| Merck Sharp & Dohme Corp. | GARDASIL | human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant | INJECTION, SUSPENSION | 125126 | 001 | 2006-06-08 | ➤ Sign Up | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | ➤ Sign Up | search | ||
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
International Patents for human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Singapore | 171804 | ➤ Sign Up |
| World Intellectual Property Organization (WIPO) | 2012071554 | ➤ Sign Up |
| Taiwan | I547502 | ➤ Sign Up |
| Country | Patent Number | Estimated Expiration |
Supplementary Protection Certificates for human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2001 00033 | Denmark | ➤ Sign Up | PRODUCT NAME: REKOMBINANT HUMANT OSTEOGENT PROTEIN-1: BMP-7; REG. NO/DATE: EU/1/01/179/001 20010517 |
| C/GB10/045 | United Kingdom | ➤ Sign Up | PRODUCT NAME: DENOSUMAB, IMMUNOGLOBULIN G2, ANTI-(HUMAN TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 11 (HUMAN OSTEOCLAST DIFFERENTIATION FACTOR)) (HUMAN MONOCLONAL AMG162 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL AMG162 LIGHT CHAIN, DIMER; REGISTERED: UK EU/1/10/618/001 20100526; UK EU/1/10/618/002 20100526; UK EU/1/10/618/003 20100526; UK EU/1/10/618/004 20100526 |
| 2016 00031 | Denmark | ➤ Sign Up | PRODUCT NAME: RITUXIMAB AND RECOMBINANT HUMAN HYALURONIDASE; NAT. REG. NO/DATE: EU/1/98/067/003-004 20140326; FIRST REG. NO/DATE: EU EU/1/98/067 20140326 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
